The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued a new scale of fees applicable across all its services, including medtech, to apply from 1 April. The 12-week consultation closed on 23 November.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?